Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rose

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 10, 2020
Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJMichael C Myers, Donna M Bilder, Cullen L Cavallaro, et al.
Breast Cancer Research and Treatment|August 11, 2018
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancerAdrienne E Borrie, Rhiannon V Rose, Yun-Hee Choi, et al.
Analytical Biochemistry|January 4, 2019
Linking (Pyr)<sup>1</sup>apelin-13 pharmacokinetics to efficacy: Stabilization and measurement of a high clearance peptide in rodentsJoelle M Onorato, Carrie Xu, Xue-Qing Chen, et al.
Journal of Medicinal Chemistry|May 28, 2025
The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule AgonistsShun Su, Michael C Myers, Donna M Bilder, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5Percy H Carter, Gregory D Brown, Robert J Cherney, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2Michael G Yang, Zili Xiao, Rulin Zhao, et al.
Nature Communications|July 14, 2025
Pulses of ocean acidification at the Triassic-Jurassic boundaryMolly Trudgill, James W B Rae, Ross Whiteford, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritisJoseph B Santella, Daniel S Gardner, John V Duncia, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672Michael G Yang, Zili Xiao, Robert J Cherney, et al.
Science Advances|November 15, 2017
Snowball Earth climate dynamics and Cryogenian geology-geobiologyPaul F Hoffman, Dorian S Abbot, Yosef Ashkenazy, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry Letters|February 10, 2020
Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJMichael C Myers, Donna M Bilder, Cullen L Cavallaro, et al.
Breast Cancer Research and Treatment|August 11, 2018
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancerAdrienne E Borrie, Rhiannon V Rose, Yun-Hee Choi, et al.
Analytical Biochemistry|January 4, 2019
Linking (Pyr)<sup>1</sup>apelin-13 pharmacokinetics to efficacy: Stabilization and measurement of a high clearance peptide in rodentsJoelle M Onorato, Carrie Xu, Xue-Qing Chen, et al.
Journal of Medicinal Chemistry|May 28, 2025
The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule AgonistsShun Su, Michael C Myers, Donna M Bilder, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5Percy H Carter, Gregory D Brown, Robert J Cherney, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2Michael G Yang, Zili Xiao, Rulin Zhao, et al.
Nature Communications|July 14, 2025
Pulses of ocean acidification at the Triassic-Jurassic boundaryMolly Trudgill, James W B Rae, Ross Whiteford, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritisJoseph B Santella, Daniel S Gardner, John V Duncia, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672Michael G Yang, Zili Xiao, Robert J Cherney, et al.
Science Advances|November 15, 2017
Snowball Earth climate dynamics and Cryogenian geology-geobiologyPaul F Hoffman, Dorian S Abbot, Yosef Ashkenazy, et al.
Pageof 21